DLeader

KumiChem is DLeader’s AI-agent platform for ASO and siRNA design, workflow generation, and data curation, accelerating drug discovery from concept to candidate.

DLeader’s KumiChem platform supports ASO and siRNA design, workflow generation, and data curation to accelerate drug development from concept to candidate.

News, insights, and updates from DLeader on AI-agent-based drug discovery and the KumiChem platform.

DLeader was featured in an interview by Nikkei Biotech ONLINE, a leading Japanese biotech industry publication. The interview introduced DLeader’s vision for Ku

Nikkei Biotechnology Online interviewed DLeader about its AI platform KumiChem, which supports RNA drug discovery from target understanding to oligonucleotide design, candidate evaluation, and prioritization.

DLeader Founder & CEO Qingwen Chen published the mini review “From small molecules to oligonucleotides: artificial intelligence for RNA-targeted drug discovery”

DLeader Founder & CEOのQingwen ChenによるMini Review「From small molecules to oligonucleotides: artificial intelligence for RNA-targeted drug discovery」が、Frontiers i

DLeader combines AI and chemistry expertise to accelerate drug discovery through its KumiChem platform.

DLeader introduces its team and advisors, which combine AI and chemistry expertise to speed up drug discovery using the KumiChem platform.

DLeader discusses investment, collaboration, and partnership opportunities in AI-driven drug discovery.

DLeader invites inquiries about investment, collaboration, and partnerships in AI drug discovery.

KumiChem is DLeader's agentic AI platform for RNA drug discovery — ASO and siRNA design, in silico toxicity screening, and data-driven candidate prioritization, from a simple prompt to a validated candidate.

KumiChem is an AI-agent platform developed by DLeader for RNA drug discovery, enabling ASO and siRNA design, in silico toxicity screening, and data-driven candidate prioritization from simple prompts to validated candidates.